FUTURE OF HEALTHCARE
GTCR | April 22, 2022
GTCR, a leading private equity firm, announced that it has entered into a Leaders Strategy™ partnership with Kelly McCrann to form Avryo Health Services, LLC. Based in San Diego, CA, Avryo Healthcare will seek to acquire companies and assets in the multi-site healthcare services industry as part of a strategy to build a market-leading company, with a focus on utilizing new technologies and operating strategies to enhance patient access and experiences.
GTCR, the firm that pioneered The Leaders Strategy™ - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth - will invest in Avryo Healthcare from its Strategic Growth Fund, a private equity fund with $2.0 billion of limited partner capital commitments. Mr. McCrann is serving as Executive Chairman of Avryo Healthcare and will make a substantial investment alongside GTCR.
Mr. McCrann has over 30 years of experience in the healthcare services industry. Prior to partnering with GTCR, Mr. McCrann most recently served as Chief Executive Officer of EyeCare Partners, the largest vertically-integrated medical vision services provider in the US. He became CEO of EyeCare Partners in 2016 and significantly grew the company via acquisition and organic growth into the largest business in the industry before completing a successful sale of the company in 2019. Prior to leading EyeCare Partners, Mr. McCrann spent more than 25 years in senior leadership roles across healthcare provider services and payor businesses, including within dental, behavioral health, ambulatory infusion and kidney dialysis.
"We are excited to partner with Kelly to build a leading company in the healthcare services industry," said Sean Cunningham, Managing Director and Co-Head of Healthcare at GTCR. "Kelly has an exceptional track record in the multi-site healthcare services space with experience across specialties, including dental and behavioral health, and a history of driving organic, de novo and M&A growth. Kelly's background, industry expertise and strategic vision make him an ideal partner as GTCR commits to build a platform in this attractive industry."
"I am thrilled to partner with GTCR to build Avryo Healthcare into a market-leading company in the multi-site healthcare services space. GTCR has deep domain expertise in healthcare, a substantial track record of creatively building platforms in this space, and a long history of backing experienced CEOs and Executive Chairs. With our partnership, Avryo Healthcare is well-positioned to create a compelling platform in healthcare provider services."
"GTCR's formation of Avryo Healthcare with Kelly is another excellent example of The Leaders Strategy™ and builds on our history of successful investments in multi-site healthcare services and the broader healthcare industry," added John Kos, Managing Director at GTCR. "We are excited to create this multi-site healthcare services platform behind Kelly and are actively looking for companies and assets in the sector, including founder-led and sponsor-backed companies."
Founded in 1980, GTCR is a leading private equity firm focused on investing in growth companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications industries. The Chicago-based firm pioneered The Leaders Strategy™ - finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $20 billion in over 250 companies. For more information, please visit www.gtcr.com. Follow us on LinkedIn.
About Avryo Healthcare
Avryo Healthcare was formed in April 2022 as a partnership between Kelly McCrann and GTCR. Avryo Healthcare's mission is to build a leading company in the multi-site healthcare provider services industry with a focus on building a company that utilizes new technologies and operating strategies to enhance patient access and experiences. For more information about Avryo Healthcare, please contact (212) 835-7042.
STENTiT | April 25, 2022
STENTiT, a medical device company bringing a novel class of regenerative endovascular implants for the treatment of cardiovascular diseases, has closed a €1.8 million seed investment round. The funding facilitates further pre-clinical development and batch production of a regenerative stent (see video) for peripheral indications. The investment was made by Dutch investors NextGen Ventures, Brabant Development Agency and the Ten Cate Investment Company.
STENTiT is an emerging player in the field of regenerative medical devices, offering a breakthrough solution for cardiovascular interventions by developing first-of-its-kind endovascular implants with regenerative capacity. Using a catheter-based approach, these devices provide the ability to restore arteries without the need for an invasive surgical intervention. The aim is to ultimately restore the affected blood vessel from the inside out to provide a lifelong solution.
As a first target indication, the company wants to improve the treatment of critical limb ischemia. This progressive form of peripheral artery disease affects almost 5 million people in the EU and the US in which the blood flow to the foot is severely being compromised. Unfortunately, current treatment options are ineffective, resulting in amputation within 6 months in 40% of these patients.
With the regenerative stent, blood flow to the foot will be maintained by securing vascular patency using temporary mechanical support and improving long-term efficacy by inducing vascular repair, thereby preventing thousands of amputations each year.
"We are excited to receive the support of these esteemed Dutch early-stage investors. This financing round validates our vision to bring a novel class of implants that can rebuild the affected blood vessels. We are looking forward taking the next steps getting our regenerative stents ready for clinical trials. With our first product, we aim to treat millions of patients suffering from peripheral artery diseases, and save their limbs from amputation."
Bart Sanders, CEO of STENTiT
STENTiT is a medical device spin-off company from the Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants. These bioresorbable devices trigger a natural healing response by the circulating blood cells, in which the implant is being replaced by new vascular tissue to restore the artery from the inside-out.
Since the establishment of the company, STENTiT has received broad international recognition and awards for its high-potential approach, covering world leading stages. As the company is currently going through the next translational phases, STENTiT is on its way to fulfill its ambition to become the new standard in endovascular treatment, providing a life-changing solution for millions of cardiovascular patients around the world.
Netsmart | April 12, 2022
Netsmart announced a partnership with Bamboo Health, a leading provider of data and healthcare IT solutions, to create a comprehensive behavioral health referral network supporting the nationwide effort to respond to the need to implement a 988 crisis management system. Through this strategic technology partnership, Netsmart and Bamboo Health will partner to create one of the most robust crisis management solutions in the market. The integrated solution will expedite access to treatment for those in crisis, connect individuals to a network of care and enable effective post-crisis care coordination.
Netsmart will integrate the Bamboo Health OpenBeds solution within the CareManager™ population health management platform, currently utilized by many health home organizations, managed care organizations, human services and post-acute care providers across the country. By working together to connect healthcare providers, emergency departments and crisis response professionals across a national network, OpenBeds and Netsmart will deliver an advanced system to help states, counties and providers respond to 988 and crisis line demands. Streamlining mobile crisis service coordination, treatment facility bed availability, electronic transfers and referrals to behavioral health services, the solution will create a full-picture view of an individual’s journey, including health history and treatment and services, making it easier for providers to get patients engaged with the right level of care they need quickly.
Netsmart and Bamboo Health are excited to announce that the Missouri Behavioral Health Council will be deploying the solution as part of a statewide approach to create a comprehensive statewide crisis network (known as Missouri Behavioral Health Connect – MOConnect). MOConnect will support crisis management for the Missouri Department of Mental Health, Missouri Behavioral Health Council (MBHC) and its member organizations, and community response and health partners across the state. With the vision of MBHC and its members, Missouri Behavioral Health Connect will validate the value of an integrated and connected statewide approach to crisis management and care coordination.
“By collaborating with Netsmart, together we will be able to strengthen our statewide networks to effectively manage and respond to crisis by integrating our OpenBeds solution within the CareManager population health and care coordination platform,” said Bamboo Health CEO Rob Cohen. “Through this innovative technology initiative, we can leverage one of the largest community-based interoperability networks in the country to connect with the larger healthcare ecosystem. Together, we enable care coordination and leverage robust data and analytics for population health management that improves patient outcomes during and post-crisis.”
MBHC, a longtime partner of Netsmart, leverages many components of the CareFabric platform and began using CareManager to eliminate data silos and streamline the complex process of operationalizing population health management in 2016. MBHC members have significantly advanced their workflows using CareManager and have expanded their use cases within the platform to additional programs, including the CCBHC model which is transforming service delivery for Community Mental Health Centers across the country.
“We are excited to be a part of this unique partnership and continue to leverage technology to enable our award-winning care teams across the state with the right technology to support delivering the best care. In Missouri, we are going ‘Beyond the Call’ in our approach to implementing the 988 Crisis Hotline by working together with all stakeholders to ensure individuals in need have not just someone to call in their time of need but connecting them to resources to enable better long term outcomes. By approaching the rollout of a comprehensive crisis system in the context of all of the behavioral health initiatives underway in Missouri, including the CCBHC model, we can make this happen.”
MBHC CEO & President Brent McGinty
The CCBHC model enables agencies to deliver a comprehensive range of physical, mental health and substance use treatment and services, providing expanded care while helping lower costs across the behavioral health ecosystem. Behavioral health providers that achieve CCBHC certification are uniquely positioned to serve as a foundation for the nation’s new crisis response system and Missouri has led the way in proving the value of the CCBHC initiative.
“We are thrilled to announce our new partnership with Bamboo Health, as we collectively redefine how states facilitate crisis management,” said Netsmart CEO Mike Valentine. “We believe teaming up with industry-leading technology providers to further extend the value of our CareFabric platform demonstrates our commitment to innovation and collaboration to meet our clients’ needs. As a longtime partner of MBHC and advocate for CCBHC funding, we couldn’t be happier to see this project come to life and continue to enhance this and other statewide efforts.”
To hear more about the Netsmart, Bamboo Health and MBHC strategic technology partnership stop by the Netsmart booth 313 at the National Council of Mental Wellbeing Conference (NATCON22) in Washington, D.C., April 11 – 13.
About Bamboo Health
Bamboo Health is a healthcare technology solutions company, focused on fostering care collaboration and providing information and actionable insights across the entire continuum of care. As one of the largest, most diverse care collaboration networks in the country, our technology solutions equip healthcare providers and payers with software, information, and insights to facilitate whole person care across the physical and behavioral health spectrums. By serving 2,500 hospitals, 8,000 post-acute facilities, 25,000 pharmacies, 32 health plans, 50 state governments, and over one million acute and ambulatory providers through more than 500 clinical information systems electronically, we impact over 1 billion patient encounters annually in provider workflow. Health systems, payers, providers, pharmacies, governments, individuals, and other organizations rely on Bamboo Health to improve care and reduce cost. Connect with Bamboo Health on Twitter, LinkedIn and Facebook. Visit www.BambooHealth.com to learn more.
About Missouri Behavioral Health Council
The Missouri Behavioral Health Council’s mission is to enable access to quality mental health services to all Missouri citizens in need of such services, while maximizing their human potential and quality of life. This mission will be accomplished through the continued maintenance and development of a stable statewide network of comprehensive community based behavioral healthcare.
Netsmart, a leading provider of Software as a Service (SaaS) technology and services solutions, designs, builds and delivers electronic health records (EHRs), health information exchanges, analytics and telehealth solutions and services that are powerful, intuitive and easy-to-use. Our platform provides accurate, up-to-date information that is easily accessible to care team members in the human services and post-acute care (which is comprised of home care and hospice and senior living) markets. We make the complex simple and personalized so our clients can concentrate on what they do best: provide services and treatment that support whole-person care.
Lark Health | March 17, 2022
Lark Health today announced the development of a novel AI-driven program for the prevention and management of atherosclerotic cardiovascular disease and coronary artery disease in collaboration with Roche Diagnostics. The program, named Lark Heart Health, is an AI-driven virtual care solution that provides personalized health coaching anytime, anywhere. The new Heart Health program is planned to launch later this year.
Cardiovascular disease is the leading cause of death globally, and nearly half of all adults in the U.S. have some form of CVD. It's also one of the most expensive chronic conditions, with heart disease and stroke costing the U.S. healthcare system roughly $214 billion annually. Yet, provider shortages and siloed care teams leave patients with limited care options, gaps in care, and insufficient education and empowerment to self-manage their heart health. Additionally, high treatment costs and resource constraints often limit care to those with the highest acuity conditions.
Built using a Cognitive Behavioral Therapy framework and designed in accordance with guidelines from the American Heart Association (AHA), Lark Heart Health will provide a cost-effective, scalable solution for continuous, person-centric remote heart health coaching intended to help users improve their healthy lifestyle behaviors, reduce stress levels, and ultimately decrease risk factors for heart disease. Through an evidence-based educational curriculum and real-time personalized coaching, Lark will provide users with the tools they need to make meaningful lifestyle changes that can help them better prevent and manage ASCVD and CAD.
Earlier this year, Lark announced it had joined the AHA's Network at American Heart Association Center of Health Technology & Innovation, which is focused on building and fostering health technology relationships to develop innovative and scalable solutions.
"Lark Heart Health will help those at high risk prevent and actively manage cardiovascular disease through personalized digital coaching. By leveraging our AI technology, we can deliver meaningful and engaging care at an unprecedented scale, and this collaboration with Roche Diagnostics will support the expansion of our proven tech platform into one of the costliest chronic disease markets."
Julia Hu, co-founder and CEO of Lark
About Lark Health
Lark is a healthcare technology company aimed at delivering infinitely scalable, virtual chronic and preventative healthcare through conversational AI. To date, Lark has provided nearly 2 million people with unlimited, 24/7 personalized care delivered through an easy-to-use, text message-like interface that integrates remote patient monitoring tools and is built on a cognitive behavioral therapy framework. Lark's platform seamlessly integrates with health plans' and employers' existing healthcare infrastructure to help them scale their chronic disease prevention and management programs, boost engagement, and improve health outcomes. Lark currently works with many of the largest health plans and across four programs: Prevention, Diabetes Prevention, Diabetes Care, and Hypertension Care. Lark's Diabetes Prevention Program, which is the fastest growing and lowest cost DPP, has received the highest level of clinical recognition—Full Recognition—from the Centers for Disease Control and Prevention. The company has received numerous accolades, including having been named as one of CB Insights Digital Health 150 (2019), a finalist for the UCSF Digital Health Awards one of Fast Company's Most Innovative Companies and one of Fierce Healthcare's Fierce 15.